Related Experiment Video
Updated: Aug 27, 2025

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
Negative Cross-Talk between TLR2/4-Independent AMPKα1 and TLR2/4-Dependent JNK Regulates S. pneumoniae-Induced
Shingo Matsuyama1, Kensei Komatsu1, Byung-Cheol Lee1
1Center for Inflammation, Immunity & Infection, Institute for Biomedical Sciences, Georgia State University, Atlanta, GA; and.
Abstract:
Streptococcus pneumoniae is major cause of otitis media (OM) and life-threatening pneumonia. Overproduction of mucin, the major component of mucus, plays a critical role in the pathogenesis of both OM and pneumonia. However, the molecular mechanisms underlying the tight regulation of mucin upregulation in the mucosal epithelium by S. pneumoniae infection remain largely unknown. In this study, we show that S. pneumoniae pneumolysin (PLY) activates AMP-activated protein kinase α1 (AMPKα1), the master regulator of energy homeostasis, which is required for S. pneumoniae-induced mucin MUC5AC upregulation in vitro and in vivo. Moreover, we found that PLY activates AMPKα1 via cholesterol-dependent membrane binding of PLY and subsequent activation of the Ca2+- Ca2+/calmodulin-dependent kinase kinase β (CaMKKβ) and Cdc42-mixed-lineage protein kinase 3 (MLK3) signaling axis in a TLR2/4-independent manner. AMPKα1 positively regulates PLY-induced MUC5AC expression via negative cross-talk with TLR2/4-dependent activation of MAPK JNK, the negative regulator of MUC5AC expression. Moreover, pharmacological inhibition of AMPKα1 suppressed MUC5AC induction in the S. pneumoniae-induced OM mouse model, thereby demonstrating its therapeutic potential in suppressing mucus overproduction in OM. Taken together, our data unveil a novel mechanism by which negative cross-talk between TLR2/4-independent activation of AMPKα1 and TLR2/4-dependent activation of JNK tightly regulates the S. pneumoniae PLY-induced host mucosal innate immune response.
Insights
Streptococcus pneumoniae infection triggers mucin overproduction via pneumolysin (PLY) activating AMP-activated protein kinase α1 (AMPKα1). Inhibiting AMPKα1 suppressed mucus in otitis media models, showing therapeutic potential.
Area of Science:
- Microbiology
- Immunology
- Molecular Biology
Background:
- *Streptococcus pneumoniae* causes otitis media and pneumonia, often involving excessive mucus production.
- The mechanisms regulating *S. pneumoniae*-induced mucin overproduction are not fully understood.
Purpose of the Study:
- To elucidate the molecular pathways by which *S. pneumoniae* induces mucin MUC5AC upregulation.
- To investigate the role of AMP-activated protein kinase α1 (AMPKα1) in this process.
- To explore the therapeutic potential of targeting AMPKα1 for otitis media.
Main Methods:
- *In vitro* and *in vivo* studies using *Streptococcus pneumoniae* infection models.
- Analysis of signaling pathways including AMPKα1, CaMKKβ, MLK3, and MAPK JNK.
- Pharmacological inhibition of AMPKα1 in an otitis media mouse model.
Main Results:
- *Streptococcus pneumoniae* pneumolysin (PLY) activates AMPKα1, essential for MUC5AC upregulation.
- PLY activates AMPKα1 through cholesterol-dependent membrane binding and a CaMKKβ/MLK3 axis, independent of TLR2/4.
- AMPKα1 positively regulates MUC5AC via cross-talk with JNK, a negative regulator.
- AMPKα1 inhibition reduced MUC5AC induction in an otitis media model.
Conclusions:
- A novel mechanism reveals AMPKα1 activation by PLY regulates mucin production.
- Negative cross-talk between AMPKα1 and JNK pathways controls the host response.
- Targeting AMPKα1 offers a potential therapeutic strategy for *S. pneumoniae*-induced mucus hypersecretion.
Related Concept Videos
The JAK-STAT Signaling Pathway
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...
cAMP-dependent Protein Kinase Pathways
MAPK Signaling Cascades
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

